Objectives: There is an urgent need for accurate and fast diagnostic tests to identify carbapenemase-producing bacteria. Here, we have evaluated a novel colorimetric test (the b-CARBA TM test; Bio-Rad) to detect carbapenemase-producing Gram-negative bacilli from cultured colonies.
Introduction
Carbapenemase-producing Enterobacteriaceae (CPE) are most often resistant to most, if not all, classes of antimicrobial molecules, and thus represent a major public health concern. 1 Carbapenem resistance may be mediated by complex processes, such as: (i) plasmid-or chromosome-encoded cephalosporinase and/or ESBL production associated with outer-membrane impermeability; and (ii) carbapenemase production. 1 Identification based solely on antibiotic susceptibility testing is not easy. 2 Using only susceptibility testing for carbapenems, even with the screening cut-offs of EUCAST (MIC 0.5 mg/L for meropenem and 0.125 mg/L for ertapenem), about 20% of CPE may be missed, especially in areas with high OXA-48 prevalences. 3 A recently proposed algorithm by the French Society of Microbiology showed that at least 66% of Enterobacteriaceae with a reduced susceptibility to at least one carbapenem required confirmatory testing. 4 Thus, reliable and simple confirmatory tests are mandatory to rapidly discriminate CPE from non-CPE. [2] [3] [4] Various phenotypic confirmation tests for detecting carbapenemases have been developed, including inhibition tests of carbapenemase activity, 2, 5 detection of carbapenem hydrolysis using MALDI-TOF MS, 6 and biochemical tests (e.g. the Carba NP test and derivatives), 7, 8 and the carbapenem inactivation method (CIM). 9 These tests are able to detect the presence of a carbapenemase activity and sometimes to discriminate between Ambler class A and Ambler class B carbapenemases (e.g. inhibition tests and the Carba NP test II and the OXA-48 disc test). 5, 10 Immunochromatographic assays, aiming to detect OXA-48-like CPE, IMP-like CPE and OXA-48/KPC CPE, respectively, from solid cultures have shown their usefulness in rapid detection of these carbapenemases. [11] [12] [13] However, to be really useful these immunochromatographic assays need to be able to detect the most common carbapenemases, including NDM and VIM. 11 Finally, molecular methods often remain the gold standard for the detection of carbapenemase producers. 2, [14] [15] [16] Recent epidemiological studies have shown that OXA-48 carbapenemases are now the most prevalent carbapenemase in many European countries. 17 In France, OXA-48-like enzymes account for 86% of the carbapenemases addressed to the French National Reference Center (T. Naas, unpublished data). Of note, although all OXA-48-like enzymes confer resistance to penicillins, only some variants possess a carbapenemase activity (OXA-48, OXA-162, OXA-181, OXA-204, OXA-232, OXA-244 and OXA-245), 18 and the level of carbapenemase resistance may sometimes be at the limit of detection, rendering their detection very difficult with commercially available phenotypic or biochemical tests (especially with OXA-232 and OXA-244). 7, 19 On the other hand, few OXA-48 variants lacking significant carbapenemase activity (OXA-163, OXA-247 and OXA-405) were described. [20] [21] [22] These variants were systematically falsely detected as OXA-48-like carbapenemases using molecular methods.
14 Similarly, many rare carbapenemases (e.g. GES, IMI, GIM and AIM) are not included in the molecular detection assays and thus may go undetected. 14, 15 Accordingly, a simple, rapid and accurate method able to detect all carbapenemase producers and discriminate them from non-carbapenemase producers is still needed. Here, we have evaluated a new colorimetric assay called the b-CARBA TM test (Bio-Rad, Marne la Coquette, France) and compared it with tests based on acidimetry-the Carba NP test, 23 the CarbAcineto NP test (for Acinetobacter spp.) 24 and RAPIDEC V R CARBA NP (bioMérieux).
7,8

Materials and methods
Strain collection
A total of 290 collection isolates with characterized b-lactamase content were used in this study. They included 176 Enterobacteriaceae, 56 Pseudomonas spp. and 58 Acinetobacter baumannii (Tables 1-3 [20] [21] [22] which usually give false positive results with molecular methods (Tables 1-3 ). 14 
MICs
MICs of carbapenems were determined using the Etest (bioMérieux, La Balmes les Grottes, France) and results were interpreted following EUCAST guidelines, as updated in 2016 (http://www.eucast.org).
Carbapenemase activity detection
The commercially available b-CARBA TM test is based on the change of colour of an undisclosed chromogenic substrate in the presence of carbapenem-hydrolysing enzymes. One colony is resuspended in 200 lL of reaction mixture and incubated at room temperature for 30 min. A colour change from yellow to orange red or purple signals the presence of a carbapenem-hydrolysing activity.
To compare the biological performance of the b-CARBA TM test, the home-made Carba NP test (for Enterobacteriaceae and Pseudomonas spp.) and CarbAcineto NP test (for Acinetobacter spp.) and commercially available RAPIDEC V R CARBA NP (bioMérieux) were tested in parallel. For this study, the strains to be tested were grown on trypticase soy agar plates (Bio-Rad) for 16-24 h at 37 C. The tests were performed according to the manufacturer's recommendations (for the b-CARBA TM test) or according to the published protocols for the Carba NP test, 25 the CarbAcineto NP test 24 and RAPIDEC V R CARBA NP. 7 
Statistical analysis
The sensitivity and specificity of the b-CARBA TM test were calculated with their respective 95% CIs on all tested strains. The gold standard was PCR followed by sequencing.
Results
Performance of the b-CARBA TM test in Enterobacteriaceae
The overall sensitivity and specificity of the b-CARBA TM test for Enterobacteriaceae reached 85.1% (95% CI 77.7%-90.4%) and 92.7% (95% CI 82.7%-97.1%), respectively ( (1/1) of the OXA-162 producers, 88.9% (8/9) of the OXA-181 producers, 20% (1/5) of the OXA-204 producers, 50% (1/2) of the OXA-232 producers and 50% (1/2) of the OXA244 producers. Eight isolates (one OXA-48, one OXA-181, four OXA-204, one OXA-232 and one OXA-244) gave repeatedly (n " 3) negative b-CARBA TM test results. These strains, except one OXA-244 producer, were positive using RAPIDEC V R CARBA NP. The Carba NP test also gave positive results for these strains except one OXA-181 and one OXA-244 that gave doubtful results, and one OXA-244 producer that remained negative (the same strain was negative with RAPIDEC V R CARBA NP) ( Table 1) . Concerning MBL producers, all IMP (n " 11), VIM (n " 17) and GIM-1 (n " 1) producers were correctly identified. For NDM producers (n " 21), two isolates, one Providencia stuartii and one Proteus rettgeri, repeatedly gave a negative test result with the b-CARBA TM test, whereas they were detected with RAPIDEC V R CARBA NP and the Carba NP test. For Ambler class A carbapenemases, all the KPC producers were perfectly identified with the three tests. Of note, however, all other Ambler class A carbapenemases, namely IMI (n " 3), NCM-A (n " 1), SME (n " 2), GES-5 (n " 1) and FRI-1 (n " 1), were repeatedly negative with the b-CARBA TM test, whereas positive results were obtained with 
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Colorimetric test for carbapenemase detection JAC RAPIDEC V R CARBA NP (all of them) and the Carba NP test (except for the GES-5 producer) (Table 1) . Finally, the b-CARBA TM test was negative for all 55 non-CPE, except for one Citrobacter freundii isolate producing TEM-3 ESBL and overexpressing its chromosomeencoded cephalosporinase and all the non-carbapenemase variants of OXA-48, namely OXA-163 (n " 2) and OXA-405 (n " 1) ( Table 1) . Of note, these three strains producing noncarbapenemase OXA-48 variants were detected as noncarbapenemase producers using RAPIDEC V R CARBA NP and the Carba NP test.
Performance of the b-CARBA
TM test in Pseudomonas spp.
The overall sensitivity and specificity of the b-CARBA TM test for Pseudomonas spp. reached 77.8% (95% CI 61.9%-88.2%) and 100% (95% CI 83.9%-100%), respectively ( Table 4 ). The b-CARBA TM test could detect 77.8% (28/36) of the carbapenemase-producing Pseudomonas spp. isolates, including KPC-2, NDM-1, VIM-, IMP-, GIM-1, SPM-1, AIM-1 and DIM-1 producers ( Table 2 ). As previously observed for Enterobacteriaceae, the four non-KPC Ambler class A carbapenemase producers (three GES-producing P. aeruginosa and one BIC-1-producing Pseudomonas fluorescens) and one Ambler class D carbapenemase producer (OXA-198-producing P. aeruginosa) remained negative with the b-CARBA TM test, even though the BIC-1 producer was detected with RAPIDEC V R CARBA NP and the Carba NP test. As previously shown, RAPIDEC V R CARBA NP and the Carba NP test were not able to detect GES-type and OXA-198 carbapenemases in Pseudomonas spp. 26 The 20 non-carbapenemase-producing P. aeruginosa (including ESBL and hyperproducing cephalosporinases) remained negative with all three assays ( Table 2) .
TM test in A. baumannii
The overall sensitivity and specificity of the b-CARBA TM test for A. baumannii reached 90.5% (95% CI 77.9%-96.2%) and 100% (95% CI 80.6%-100%), respectively ( Table 4 ). The b-CARBA TM test could detect 90.5% (38/42) of the carbapenemase-producing A. baumannii (Table 3) . These carbapenemases included 34 OXA carbapenemases (10 OXA-23-like, 13 OXA-24/-40-like, 4 OXA-51 with ISAbaI, 5 OXA-58-like, 2 OXA-143-like) and 7 MBLs (3 NDM-1, 2 IMP-like, 1 VIM-4 and 1 SIM-1). One OXA-51 with ISAbaI out of the four tested gave a positive b-CARBA TM test result, while all four were negative with RAPIDEC V R CARBA NP and the CarbAcineto NP test. The GES-14-producing A. baumannii gave a negative result with all three assays ( V R CARBA NP was 94.8% (95% CI 91.0%-97.3%) sensitive and 100% (95% CI 95.6%-100%) specific using this same collection, in accordance with previous studies. 7, 8 The lack of sensitivity observed with the b-CARBA TM test is mostly due to the poor detection of OXA-204, OXA-232 and OXA-244 producers and to the absence of detection of all non-KPC Ambler class A carbapenemases, namely IMI, NMC-A, SME, FRI-1, BIC-1, GES-2 and GES-5. Although the exact chromogenic b-lactam compound present in the b-CARBA TM test is not known, we could speculate that this molecule may not be able to enter efficiently into the active site of the IMI, SME, BIC-1 and FRI-1 enzymes, as is the case for thirdgeneration cephalosporins. Indeed, intriguingly, as opposed to KPC, these Ambler class A carbapenemases are not able to efficiently hydrolyse expanded-spectrum cephalosporins. 27 However, NMC-A, IMI, SME, FRI-1, BIC-1 and GES-type carbapenemases are still rare.
In order to know whether the b-CARBA TM test would be useful for countries in Europe, we have extrapolated our results to the French epidemiology of CPE, as observed between 2012 and 2015. During that period 9518 enterobacterial isolates with reduced susceptibility to at least one carbapenem were received by the French National Reference Center for CPE and 3320 of them were confirmed as CPE. These isolates originated from hospitals and from community-serving clinical diagnostic laboratories scattered throughout France. They included 118 KPC, 13 IMI, 1 FRI-1, 366 NDM, 115 VIM, 10 IMP, 2491 OXA-48, 120 OXA-181, 35 OXA-204, 8 OXA-232, 10 OXA-244 and 33 multiple carbapenemase producers (including 30 NDM ! OXA-48-like, 1 NDM ! VIM and 2 VIM ! OXA-48-like). Using our test results, we would expect that the b-CARBA TM test would detect all OXA-48 producers, but only 90% of OXA-181 producers, 20% of OXA-204 producers, 50% of OXA-232 and 50% of OXA 244 producers, but none of the non-KPC class A carbapenemases. During this period, the Carba NP test was performed on all isolates allowing the detection of all IMI and FRI-1 producers, but failed to detect 9 OXA-48, 14 OXA-181, 4 OXA-232 and 9 OXA-244 producers. Taking into account these detection problems for certain OXA-48-variants and class A carbapenemases other than KPCs, the b-CARBA TM test would be able to detect 98.74% of all CPE isolated between 2012 and 2015 (Table 4) , leading to 98.74% (95% CI 98.30%-99.06%) sensitivity and 99.97% (95% CI 99.88%-99.99%) specificity. These performance results are in accordance with those of the Xpert V R Carba-R v2, which has recently been found to be able to detect 99.6% (2018/ 2026) of all the CPE identified by the French National Reference Center between 2012 and 2014, missing only seven IMI producers and one FRI-1 producer.
14 Given these high performance results, the b-CARBA TM test could be considered to be a reliable confirmatory test for: (i) all enterobacterial isolates with decreased susceptibility to carbapenems (inhibition diameters ,25, , 23 and ,25 mm for meropenem, imipenem and ertapenem, respectively, according to the EUCAST recommendations); and (ii) colonies growing on CPE screening media. In addition, the b-CARBA TM test can be easily performed by untrained personnel and it seems to lead to less doubtful interpretation as compared with the Carba NP test or RAPIDEC V R CARBA NP. 7, 8 The test gives easy-to-read results after only 30 min of incubation as compared with 2 h for the Carba NP test and RAPIDEC V R CARBA NP, providing a very quick answer as to whether the strain produces a carbapenem-hydrolysing enzyme. However, although non-KPC Ambler class A carbapenemases are still rare, microbiologists should keep in mind that because their encoding genes are most often not included in commercially available molecular diagnostic tests, the unique possibility of detecting these carbapenemases resides in biochemical tests able to detect a carbapenemase activity (e.g. the Carba NP test, RAPIDEC V R CARBA NP and the b-CARBA TM test). Unfortunately, for this purpose the b-CARBA TM test completely failed to detect these non-KPC Ambler class A carbapenemases, which may thus lead to outbreaks. 28 The identification of plasmid-encoded IMItype enzymes in clinical Escherichia coli isolates indicates that this kind of resistance trait is likely to be isolated more frequently. 29 Finally, as the spread of OXA-48 continues, its diversification may also increase.
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